Ich stimme zu, dass diese Seite Cookies verwende. Weitere Informationen finden Sie unter unseren Datenschutzerklärungen .
X
Neimark, E. D.
149  Ergebnisse:
Personensuche X
?
1

DOP53 Long-term Efficacy and Safety of Risankizumab in Pati..:

Ferrante, M ; Panaccione, R ; Colombel, J F...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i168-i170 , 2024
Link: https://doi.org/10.1093/..
 
?
2

DOP10 Risankizumab Versus Ustekinumab for the Achievement o..:

Peyrin-Biroulet, L ; Bossuyt, P ; Regueiro, M...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i90-i91 , 2024
Link: https://doi.org/10.1093/..
 
?
3

OP06 Risankizumab Maintenance Therapy in Patients With Mode..:

Louis, E ; Panaccione, R ; Parkes, G...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i10-i12 , 2024
Link: https://doi.org/10.1093/..
 
?
4

DOP64 Steroid-sparing effect of risankizumab vs ustekinumab..:

Raine, T ; Danese, S ; Schreiber, S...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i190-i190 , 2024
Link: https://doi.org/10.1093/..
 
?
5

P593 Efficacy of Risankizumab in Patients With Moderately t..:

Panaccione, R ; Louis, E ; Colombel, J F...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i1153-i1155 , 2024
Link: https://doi.org/10.1093/..
 
?
6

OP36 Risankizumab Versus Ustekinumab for the Achievement of..:

Dubinsky, M C ; D'Haens, G ; Atreya, R...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i65-i66 , 2024
Link: https://doi.org/10.1093/..
 
?
7

DOP18 Efficacy of risankizumab versus ustekinumab by baseli..:

Peyrin-Biroulet, L ; Colombel, J F ; D'Haens, G...
Journal of Crohn's and Colitis.  18 (2024)  Supplement_1 - p. i104-i105 , 2024
Link: https://doi.org/10.1093/..
 
?
8

P548 Efficacy outcomes of placebo maintenance treatment in ..:

Atreya, R ; Irving, P ; Fujiya, M...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i675-i677 , 2023
Link: https://doi.org/10.1093/..
 
?
9

P661 Clinical response over 24 weeks for initial and delaye..:

Panaccione, R ; Dotan, I ; Ferrante, M...
Journal of Crohn's and Colitis.  17 (2023)  Supplement_1 - p. i790-i791 , 2023
Link: https://doi.org/10.1093/..
 
?
10

P544 Patients with moderate to severe Crohn's disease with ..:

D'Haens, G ; Beaton, M ; Bossuyt, P...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i491-i491 , 2022
Link: https://doi.org/10.1093/..
 
?
11

DOP83 Normalisation of biomarkers and improvement in clinic..:

Atreya, R ; Feagan, B ; Shchukina, O...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i126-i127 , 2022
Link: https://doi.org/10.1093/..
 
?
12

DOP82 Achievement of steroid-free remission in patients wit..:

Schreiber, S W ; Cross, R ; Panaccione, R...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i125-i126 , 2022
Link: https://doi.org/10.1093/..
 
?
13

DOP84 Risankizumab maintenance therapy results in sustained..:

Irving, P M ; Abreu, M ; Axler, J...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i127-i128 , 2022
Link: https://doi.org/10.1093/..
 
?
14

A37 EFFICACY AND SAFETY OF RISANKIZUMAB AS MAINTENANCE THER..:

Panaccione, R ; Ferrante, M ; Feagan, B G...
Journal of the Canadian Association of Gastroenterology.  5 (2022)  Supplement_1 - p. 43-45 , 2022
Link: https://doi.org/10.1093/..
 
?
15

OP25 Patients with moderate to severe Crohn's Disease with ..:

Ferrante, M ; Cao, Q ; Fujii, T...
Journal of Crohn's and Colitis.  16 (2022)  Supplement_1 - p. i027-i028 , 2022
Link: https://doi.org/10.1093/..
 
1-15